ACCENTIA BIOPHARMACEUTICALS INC Debt Conversion, Converted Instrument, Amount
ACCENTIA BIOPHARMACEUTICALS INC reported Debt Conversion, Converted Instrument, Amount of $13.71 million for the 12-month period ending 2011-09-30, per its 10-K filed 2012-12-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC debt conversion, converted instrument, amount for fiscal 2011 was $13.71M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2011-09-30 | $13.71M 10-K · filed 2012-12-26 |